Download PDF
Z Gastroenterol 2020; 58(12): 1191-1200
DOI: 10.1055/a-1283-6832
Originalarbeit

Iron deficiency, depression, and fatigue in inflammatory bowel diseases

Eisenmangel, Depression und Erschöpfung bei CED
Peter König
1   Div. of Gastroenterology and Hepatology, Dept Medicine 3
2   Dept. of Psychiatry
,
Kristine Jimenez
1   Div. of Gastroenterology and Hepatology, Dept Medicine 3
,
Gerda Saletu-Zyhlarz
2   Dept. of Psychiatry
,
Martina Mittlböck
3   Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria
,
Christoph Gasche
1   Div. of Gastroenterology and Hepatology, Dept Medicine 3
4   Loha for Life, Centre of Excellence for Iron Deficiency, Vienna, Austria
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Iron deficiency and anemia are common findings in IBD. Treatment of anemia improves quality of life. Neurological symptoms like depression or anxiety are also common in IBD; however, their relationship with ID has not been studied in detail.

Methods Prospective, single center, non-interventional trial in an IBD cohort (n = 98), which is generally at risk for ID. Quality of sleep (using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Insomnia Severity Index) and the presence of fatigue (Piper fatigue scale), depression (Self-rating Depression Scale [SDS]) or anxiety (Self-rating Anxiety Scale [SAS]) were related to ID (ferritin, transferrin saturation), anemia (hemoglobin), and inflammatory disease activity (CRP).

Results ID was present in 35 %, anemia in 16 %, and inflammation in 30 %. The overall quality of sleep in this cohort was similar to that reported for the general population. ID, anemia, or inflammation had no influence on the PSQI (median 4.0 [CI 3.0–5.0]), the ESS 5.5 (5.0–7.0), and the ISI 4.00 (2.5–5.5). Fatigue (PFS; present in 30 %), anxiety (SAS; present in 24 %), and depression (SDS; present in 33 %) were more common than in the general population. Iron deficient and anemic patients were more likely to be depressed (p = 0.02 and p < 0.01) and showed a trend towards presence of fatigue (p = 0.06 and 0.07). Systemic inflammation as measured by CRP had no effect on any of these conditions.

Conclusion In this IBD cohort, ID and anemia affect depression and possibly fatigue independent of the presence of inflammation.

Zusammenfassung

Hintergrund Eisenmangel und Anämie sind häufige extraintestinale Komplikationen der chronisch entzündlichen Darmerkrankungen (CED). Eine Behandlung der Anämie verbessert die Lebensqualität. Neurologische Symptome wie Depression oder Angst sind ebenfalls häufig bei CED; deren Zusammenhang mit Eisenmangel wurde aber noch nicht untersucht.

Methoden Prospektive, monozentrische, nichtinterventionelle Studie an Patienten mit CED (n = 98). Schlafqualität (mittels PSQI-Pittsburgh Sleep Quality Index, ESS-Epworth Sleepiness Scale, und ISI-Insomnia Severity Index) und das Vorliegen von Erschöpfung (PFS-Piper fatigue scale), Depression (SDS-Self-rating Depression Scale) oder Angst (SAS-Self-rating Anxiety Scale) und deren Zusammenhang mit Eisenmangel (Ferritin, Transferrinsättigung), Anämie (Hämoglobin) oder Entzündung (CRP) wurden untersucht.

Ergebnisse Eisenmangel war bei 35 % der CED-Patienten vorhanden, Anämie in 16 % und Entzündung in 30 % der Fälle. Die Schlafqualität war gesunden Probanden ähnlich. Ergebnisse der PQSI (median 4,0 [KI 3,0–5,0]), ESS 5,5 (5,0–7,0) und ISI 4,00 (2,5–5,5) wurden nicht durch Eisenmangel, Anämie, oder Entzündung beeinflusst. Erschöpfung (PFS; 30 % Prävalenz), Angst (SAS; 24 % Prävalenz) und Depression (SDS, 33 % Prävalenz) waren häufiger bei CED als in der Allgemeinbevölkerung. IBD-Patienten mit Eisenmangel oder Anämie waren häufiger depressiv (p = 0,02 and p < 0,01) und tendierten häufiger zu Erschöpfung (p = 0,06 and 0,07). Entzündungsaktivität – gemessen an CRP – hatte keinen Einfluss auf die Untersuchungsergebnisse.

Schlussfolgerung In dieser IBD-Kohorte beeinflussen Eisenmangel und Anämie die Depression und möglicherweise die Erschöpfung, unabhängig von vorhandener Entzündung.

Key words

IBD - iron deficiency - anxiety - depression - quality of life - quality of sleep

Schlüsselwörter

CED - Eisenmangel - Angst - Depression - Lebensqualität - Schlafqualität

Supplement



Publication History

Received: 03 June 2020

Accepted: 30 September 2020

Article published online:
08 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther 2006; 24: 1507-1523 . doi:10.1111/j.1365-2036.2006.03146.x
    CrossrefPubMedGoogle Scholar
  • 2 Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012; 61: 933-952 . doi:10.1136/gut.2010.214312
    CrossrefPubMedGoogle Scholar
  • 3 Oustamanolakis P, Koutroubakis IE, Messaritakis I. et al Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23: 262-268 . doi:10.1097/MEG.0b013e328343b885
    CrossrefPubMedGoogle Scholar
  • 4 Gasche C, Berstad A, Befrits R. et al Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-1553 . doi:10.1002/ibd.20285
    CrossrefPubMedGoogle Scholar
  • 5 Wurzinger B, Konig P. [Iron deficiency, fatigue and restless-legs-syndrome]. Wiesner medizinische Wochenschrift 2016; 166: 447-452 . doi:10.1007/s10354-016-0497-3
    PubMedGoogle Scholar
  • 6 Gonzalez Alayon C, Pedrajas Crespo C, Pedrosa M. et al Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. Gastroenterologia y hepatologia 2018; 41: 22-29 . doi:10.1016/j.gastrohep.2017.07.011
    CrossrefPubMedGoogle Scholar
  • 7 Wells CW, Lewis S, Barton JR. et al Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123-130 . doi:10.1097/01.MIB.0000196646.64615.db
    CrossrefPubMedGoogle Scholar
  • 8 van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010; 32: 131-143 . doi:10.1111/j.1365-2036.2010.04347.x
    CrossrefPubMedGoogle Scholar
  • 9 Evstatiev R, Marteau P, Iqbal T. et al FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-853.e2 . doi:10.1053/j.gastro.2011.06.005
    CrossrefPubMedGoogle Scholar
  • 10 Gasché C, Dejaco C, Waldhoer T. et al Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997; 126: 782-787
    CrossrefPubMedGoogle Scholar
  • 11 Favrat B, Balck K, Breymann C. et al Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study. PloS One 2014; 9: e94217 . doi:10.1371/journal.pone.0094217
    CrossrefPubMedGoogle Scholar
  • 12 Krayenbuehl PA, Battegay E, Breymann C. et al Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011; 118: 3222-3227 . doi:10.1182/blood-2011-04-346304
    CrossrefPubMedGoogle Scholar
  • 13 Bruner AB, Joffe A, Duggan AK. et al Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996; 348: 992-996 . doi:10.1016/S0140-6736(96)02341-0
    CrossrefPubMedGoogle Scholar
  • 14 Verdon F, Burnand B, Stubi CLF. et al Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ (Clinical research ed) 2003; 326: 1124 . doi:10.1136/bmj.326.7399.1124
    CrossrefPubMedGoogle Scholar
  • 15 Byrne G, Rosenfeld G, Leung Y. et al Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 2017; 2017: 6496727 . doi:10.1155/2017/6496727
    CrossrefPubMedGoogle Scholar
  • 16 Neuendorf R, Harding A, Stello N. et al Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res 2016; 87: 70-80 . doi:10.1016/j.jpsychores.2016.06.001
    CrossrefPubMedGoogle Scholar
  • 17 Choi K, Chun J, Han K. et al Risk of anxiety and depression in patients with inflammatory bowel disease: a nationwide, population-based study. J Clin Med 2019; 8 DOI: 10.3390/jcm8050654.
    CrossrefPubMedGoogle Scholar
  • 18 Bernstein CN. Psychological stress and depression: risk factors for IBD?. Dig Dis 2016; 34: 58-63 . doi:10.1159/000442929
    CrossrefPubMedGoogle Scholar
  • 19 Gasche C, Scholmerich J, Brynskov J. et al A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15
    CrossrefPubMedGoogle Scholar
  • 20 Silverberg MS, Satsangi J, Ahmad T. et al Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19: 5A-36A
    CrossrefPubMedGoogle Scholar
  • 21 WHO. Nutritional anaemias. Report of a WHO scientific group. World Health Organization Technical Report Series 1968; 405: 5-37
    PubMedGoogle Scholar
  • 22 Buysse DJ, Reynolds CF, Monk TH. et al The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
    CrossrefPubMedGoogle Scholar
  • 23 Riemann D, Backhaus J. [Group therapy approaches in primary/psychophysiologic insomnias]. Wiener medizinische Wochenschrift 1995; 145: 529-532
    PubMedGoogle Scholar
  • 24 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545
    CrossrefPubMedGoogle Scholar
  • 25 Bloch KE, Schoch OD, Zhang JN. et al German version of the Epworth Sleepiness Scale. Respiration 1999; 66: 440-447 . doi:10.1159/000029408
    CrossrefPubMedGoogle Scholar
  • 26 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001; 2: 297-307
    CrossrefPubMedGoogle Scholar
  • 27 Gerber M, Lang C, Lemola S. et al Validation of the German version of the insomnia severity index in adolescents, young adults and adult workers: results from three cross-sectional studies. BMC Psychiatry 2016; 16: 174 . doi:10.1186/s12888-016-0876-8
    CrossrefPubMedGoogle Scholar
  • 28 Piper BF. Piper fatigue scale available for clinical testing. Oncol Nurs Forum 1990; 17: 661-662
    PubMedGoogle Scholar
  • 29 Radbruch L, Sabatowski R, Elsner F. et al Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage 2003; 25: 449-458 . doi:10.1016/s0885-3924(03)00073-3
    CrossrefPubMedGoogle Scholar
  • 30 Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379 . doi:10.1016/S0033-3182(71)71479-0
    CrossrefPubMedGoogle Scholar
  • 31 Hinz A, Glaesmer H, Brahler E. et al Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med 2017; 30: 57-63 . doi:10.1016/j.sleep.2016.03.008
    CrossrefPubMedGoogle Scholar
  • 32 Zeitlhofer J, Schmeiser-Rieder A, Tribl G. et al Sleep and quality of life in the Austrian population. Acta Neurol Scand 2000; 102: 249-257 . doi:10.1034/j.1600-0404.2000.102004249.x
    CrossrefPubMedGoogle Scholar
  • 33 Sander C, Hegerl U, Wirkner K. et al Normative values of the Epworth Sleepiness Scale (ESS), derived from a large German sample. Sleep Breath 2016; 20: 1337-1345 . doi:10.1007/s11325-016-1363-7
    CrossrefPubMedGoogle Scholar
  • 34 Kroenke K, Wood DR, Mangelsdorff AD. et al Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. J Am Med Assoc 1988; 260: 929-934
    CrossrefPubMedGoogle Scholar
  • 35 Bromet E, Andrade LH, Hwang I. et al Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90 . doi:10.1186/1741-7015-9-90
    CrossrefPubMedGoogle Scholar
  • 36 Häuser W, Janke KH, Klump B. et al Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011; 17: 621-632 . doi:10.1002/ibd.21346
    CrossrefPubMedGoogle Scholar
  • 37 Lee HS, Chao HH, Huang WT. et al Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: a nationwide database analysis. BMC Psychiatry 2020; 20: 216 . doi:10.1186/s12888-020-02621-0
    CrossrefPubMedGoogle Scholar
  • 38 Yi S, Nanri A, Poudel-Tandukar K. et al Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees. Psychiatry Research 2011; 189: 368-372 . doi:10.1016/j.psychres.2011.03.009
    CrossrefPubMedGoogle Scholar
  • 39 Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M. et al The relationship between depression and serum ferritin level. Eur J Clin Nutr 2007; 61: 532-535 . doi:10.1038/sj.ejcn.1602542
    CrossrefPubMedGoogle Scholar
  • 40 Shafi M, Taufiq F, Mehmood H. et al Relation between depressive disorder and iron deficiency anemia among adults reporting to a secondary healthcare facility: a hospital-based case control study. J Coll Physicians Surg Pak 2018; 28: 456-559 . doi:10.29271/jcpsp.2018.06.456
    CrossrefPubMedGoogle Scholar
  • 41 Stewart R, Hirani V. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosom Med 2012; 74: 208-213 . doi:10.1097/PSY.0b013e3182414f7d
    CrossrefPubMedGoogle Scholar
  • 42 Dama M, Van Lieshout RJ, Mattina G. et al Iron deficiency and risk of maternal depression in pregnancy: an observational study. J Obstet Gynaecol Can 2018; 40: 698-703 . doi:10.1016/j.jogc.2017.09.027
    CrossrefPubMedGoogle Scholar
  • 43 Sheikh M, Hantoushzadeh S, Shariat M. et al The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial. Eur J Nutr 2017; 56: 901-908 . doi:10.1007/s00394-015-1140-6
    CrossrefPubMedGoogle Scholar
  • 44 Best WR, Becktel JM, Singleton JW. et al Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 1976; 70: 439-444
    CrossrefPubMedGoogle Scholar
  • 45 Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (Clinical research ed) 1989; 298: 82-86
    CrossrefPubMedGoogle Scholar
  • 46 Hauser G, Tkalcić M, Stimac D. et al Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll Antropol 2011; 35 (Suppl. 02) 203-207
    PubMedGoogle Scholar
  • 47 Remes O, Brayne C, van der Linde R. et al A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and Behavior 2016; 6: e00497 . doi:10.1002/brb3.497
    CrossrefPubMedGoogle Scholar
  • 48 Jonefjall B, Simren M, Lasson A. et al Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. United European Gastroenterol J 2018; 6: 148-158 . doi:10.1177/2050640617703868
    CrossrefPubMedGoogle Scholar
  • 49 Goldenberg BA, Graff LA, Clara I. et al Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease?. Am J Gastroenterol 2013; 108: 1392-1397 . doi:10.1038/ajg.2013.14
    CrossrefPubMedGoogle Scholar
  • 50 Herrera-deGuise C, Casellas F, Robles V. et al Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Inflamm Bowel Dis 2016; 22: 1450-1455 . doi:10.1097/MIB.0000000000000768
    CrossrefPubMedGoogle Scholar
  • 51 Meyer-Klaucke W, Winkler H, Schünemann V. et al Mössbauer, electron-paramagnetic-resonance and X-ray-absorption fine-structure studies of the iron environment in recombinant human tyrosine hydroxylase. Eur J Biochem 1996; 241: 432-439
    CrossrefPubMedGoogle Scholar
  • 52 Kulnigg S, Stoinov S, Simanenkov V. et al A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-1192 . doi:10.1111/j.1572-0241.2007.01744.x
    CrossrefPubMedGoogle Scholar
  • 53 Preiss JC, Bokemeyer B, Buhr HJ. et al [Updated German clinical practice guideline on “Diagnosis and treatment of Crohn’s disease” 2014]. Z Gastroenterol 2014; 52: 1431-1484 . doi:10.1055/s-0034-1385199
    PubMedGoogle Scholar
  • 54 van Leeuwen P, Dignass A, Kucharzik T. et al Z Gastroenterol 2019; 57: e397-e402 . doi:10.1055/a-1015-7324
    Article in Thieme ConnectPubMed
  • 55 Hou JK, Gasche C, Drazin NZ. et al Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2017; 23: 35-43 . doi:10.1097/MIB.0000000000000953
    CrossrefPubMedGoogle Scholar
  • 56 Lewis K, Marrie RA, Bernstein CN. et al The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis 2019; 25: 1674-1680 . doi:10.1093/ibd/izz045
    CrossrefPubMedGoogle Scholar